RI Intranet Portal
Message from the Interim Executive Director
The RI-MUHC in Numbers
Our Vision and Mission
RI-MUHC Board of Directors
Research across Our Sites
News and Events
Study at the RI-MUHC
The Desjardins Centre for Advanced Training
Reasons to work at the RI-MUHC
How a few drops of blood led to a breakthrough in immunology
Scientists from the Research Institute of the McGill University Health Centre (RI-MUHC) may have cracked the code to understanding...
Biofilms—the eradication has begun
Have you ever heard of biofilms? They are slimy, glue-like membranes that are produced by microbes, like bacteria and fungi, in order to...
Interview with Dr. Don Sheppard
Touching down in Frankfurt en route to Beirut to deliver a lecture on human fungal disease, Dr. Don Sheppard willingly makes time to share...
Doctoral student Necola Guerrina: Connecting basic respiratory research with clinical needs
Necola Guerrina is unlikely to become the stereotypical solitary scientist. This doctoral student in pathology has a talent for communication and collaboration...
On the genetics trail
Researchers have identified the genetic mutation responsible for one patient's serious health problems, finally solving a medical...
New marker and potential therapy for triple negative breast cancer
Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...
A surprise advance in the treatment of adult cancers
A team of researchers at the Research Institute of the McGill University Health Centre (RI-MUHC) has found an epigenetic modification that might be the cause of...
New marker identified for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...
A key to unlocking the mystery of triple negative breast cancer
A study conducted at the Research Institute of the McGill University Health Centre (RI-MUHC) suggests screening breast cancer patients for the prolactin receptor...
RI-MUHC researchers discover new path to stop the spread of cancer
Investigators from the Research Institute of the McGill University Health Centre (RI-MUHC), and the Institute of Cancer Research, London (UK), have discovered...